生物制药公司Outlook Therapeutics, Inc.宣布，将持续与美国食品药品监督管理局（FDA）保持密切对话，旨在进一步明确监管机构对确认性证据要求的具体立场，并共同商定最合适的后续发展路径。
生物制药公司Outlook Therapeutics, Inc.宣布，将持续与美国食品药品监督管理局（FDA）保持密切对话，旨在进一步明确监管机构对确认性证据要求的具体立场，并共同商定最合适的后续发展路径。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.